ヘルスケア市場におけるデジタルツイン – 2030年までの世界予測

Digital Twins in Healthcare Market - Global Forecast to 2030

ヘルスケア市場におけるデジタルツイン - コンポーネント(ソフトウェア、サービス)、用途(パーソナライズ医療、創薬、医療教育、ワークフロー最適化)、エンドユーザー(医療提供者、研究機関、学術機関、支払者)、および地域別 - 2030年までの世界予測
Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2030

商品番号 : SMB-36447

出版社MarketsandMarkets
出版年月2025年5月
ページ数255
図表数281
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

本レポートは、ヘルスケア市場におけるデジタルツインを分析しています。タイプ、コンポーネント、アプリケーション、エンドユーザー、地域に基づいて、様々な市場セグメントの市場規模と将来の成長ポテンシャルを推定することを目的としています。また、この市場における主要プレーヤーの競合分析に加え、各社の企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても提供しています。

The global digital twin healthcare market is experiencing significant growth in 2024, driven by the growing applications of digital twins in healthcare and growing investments by public & private entities. The market is projected to reach USD 59.94 billion by 2030 from USD 4.47 billion in 2025, at a CAGR of 68.0% during the forecast period.

世界のデジタルツイン・ヘルスケア市場は、医療分野におけるデジタルツインの活用拡大と、官民両機関による投資の増加に牽引され、2024年には大幅な成長を遂げる見込みです。市場規模は、2025年の44億7,000万米ドルから2030年には599億4,000万米ドルに達し、予測期間中は年平均成長率(CAGR)68.0%で成長すると予測されています。

ヘルスケア市場におけるデジタルツイン - 2030年までの世界予測
digital-twins-in-healthcare-market-Overview

Public and private entities increasingly invest in digital twin technologies, recognizing their potential to drive innovation and enhance operational efficiency. Quibim, based in Valencia, is at the forefront of using imaging biomarkers for precision medicine. The company has recently completed a Series A funding round worth USD 50.6 million to establish a presence in the United States. Quibim views this as a significant step towards creating human digital twins—dynamic models that enable health monitoring and improve patient stratification, increase drug development success rates, and facilitate treatment testing before implementation.

官民両組織は、デジタルツイン技術がイノベーションを推進し、業務効率を向上させる可能性を認識し、投資を拡大しています。バレンシアに拠点を置くQuibimは、精密医療における画像バイオマーカーの活用において最前線に立っています。同社は最近、米国での事業展開を目指し、シリーズAの資金調達ラウンドで5,060万米ドルを調達しました。Quibimは、この資金調達を、人間のデジタルツインの構築に向けた重要な一歩と捉えています。デジタルツインとは、健康状態のモニタリング、患者の層別化の改善、医薬品開発の成功率の向上、そして治療導入前の試験の促進を可能にする動的モデルです。

“By application, the surgical planning & medical education segment accounted for the largest share of the market in 2024.”

In 2024, the surgical planning & medical education application segment accounted for the largest share of the market. The growth of this segment is due to the integration of digital twins with virtual reality platforms, which enhances surgical training for residents. This technology allows them to simulate procedures tailored to patients’ unique anatomical and physiological characteristics. As a result, trainees can experience a realistic representation of performance and track intraoperative metrics. Several companies have developed simulations of medical anatomy and surgical procedures to reduce the reliance on cadavers and promote interactive learning.

“By end user, the healthcare providers segment accounted for the largest share of the market in 2024.”

By end user, the healthcare providers segment accounted for the largest share of the market in 2024. The growth of this segment is attributed to its important role in workflow management and surgical planning. Digital twins offer additional benefits, such as accurate patient modeling, personalized treatment planning, and ongoing monitoring. These advantages contribute to enhanced clinical decision-making and improved patient outcomes.

“By region, Europe accounted for the second-largest market share in 2024.”

Europe accounted for the second-largest share of the market in 2024. Factors influencing advancements in healthcare include increased technological investments and the use of digital twins for research and genomics. According to the European Institute of Innovation & Technology (EIT) Health Germany, European nations are implementing digital twins to improve medication prescriptions. For example, the French company ExactCure, which specializes in digital health, is focused on preventing adverse drug effects. By utilizing cutting-edge omics, sensing, computing, and communication technologies, DigiTwins aims to enable completely personalized and preventive medicine, leading to a paradigm shift in healthcare.

The breakdown of primary participants is as mentioned below:

  • By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
  • By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
  • By Region – North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Key Players in the Digital Twins in Healthcare Market

The key players operating in the digital twin in healthcare market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc.  (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc.  (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).

ヘルスケア市場におけるデジタルツイン - 2030年までの世界予測 ecosystem
digital-twins-in-healthcare-market-Ecosystem

Research Coverage:

The report analyzes the Digital Twins in Healthcare Market. It aims to estimate the market size and future growth potential of various market segments based on type, component, application, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms and new entrants/smaller firms to gauge the market’s pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights on:

Analysis of key drivers (increasing Investments in digital twins in developed as well as emerging technology adoption, rising demand for personalized medicine, increasing funding and investments in digital twin startups), restraints (accuracy and privacy issues with digital twin systems and high implementation costs), opportunities (growing importance of digital twin Iin emerging market, increasing focus on cutting edge real-time data analytics), and challenges (lack of technical expertise & data management issues) influencing the growth of the digital twin market

  • Product/Service Development & Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the digital twins in healthcare market
  • Market Development: Comprehensive information on the lucrative emerging markets by type, component, application, end user, and region
  • Market Diversification: Comprehensive information about product portfolios, expanding geographies, recent developments, and investments in the market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the digital twins in healthcare market

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.3           MARKET SCOPE                26

1.3.1        MARKETS & REGIONS COVERED               26

1.3.2        INCLUSIONS & EXCLUSIONS       27

1.3.3        YEARS CONSIDERED      28

1.3.4        CURRENCY CONSIDERED            28

1.4           MARKET STAKEHOLDERS            28

2               RESEARCH METHODOLOGY       29

2.1           RESEARCH APPROACH  29

2.1.1        SECONDARY RESEARCH                29

2.1.1.1    Key data from secondary sources       30

2.1.2        PRIMARY RESEARCH       31

2.1.2.1    Key data from primary sources           32

2.1.2.2    Breakdown of primaries      32

2.1.2.3    Insights from primary experts             33

2.2           MARKET SIZE ESTIMATION         33

2.3           MARKET BREAKDOWN DATA TRIANGULATION                 37

2.4           STUDY ASSUMPTIONS  38

2.5           RISK ASSESSMENT           38

2.6           RESEARCH LIMITATIONS             39

2.6.1        METHODOLOGY-RELATED LIMITATIONS           39

2.6.2        SCOPE-RELATED LIMITATIONS                 39

3               EXECUTIVE SUMMARY  40

4               PREMIUM INSIGHTS       45

4.1           DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW                 45

4.2           NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY COMPONENT AND COUNTRY (2025)                 46

4.3           DIGITAL TWINS IN HEALTHCARE MARKET: COUNTRY MIX        46

4.4           DIGITAL TWINS IN HEALTHCARE MARKET: REGIONAL MIX        47

4.5           DIGITAL TWINS IN HEALTHCARE MARKET:

DEVELOPED MARKETS VS. EMERGING ECONOMIES       47

5               MARKET OVERVIEW       48

5.1           INTRODUCTION              48

5.2           MARKET DYNAMICS       48

5.2.1        MARKET DRIVERS            49

5.2.1.1    Increasing investments by public and private entities    49

5.2.1.2    Growing applications of digital twins                50

5.2.1.3    Technological advancements              50

5.2.1.4    Growing funding and investments in digital twin startups                 51

5.2.2        RESTRAINTS      51

5.2.2.1    Managing data quality, privacy issues, and

high implementation costs  51

5.2.3        OPPORTUNITIES              52

5.2.3.1    Increasing focus on cutting-edge real-time data analytics                 52

5.2.3.2    Growing importance of digital twins in emerging economies                 52

5.2.4        CHALLENGES    53

5.2.4.1    Lack of skilled professionals                53

5.2.4.2    Integration with existing systems and outdated digital infrastructure        53

5.3           INDUSTRY TRENDS         53

5.3.1        TRANSFORMATION IN CLINICAL TRIALS              53

5.3.2        REVOLUTIONIZING MEDICAL TRAINING AND DIAGNOSTICS   54

5.3.3        IMPROVING OPERATIONAL EFFICIENCY IN HOSPITALS                 54

5.4           TECHNOLOGY ANALYSIS             54

5.4.1        TECHNOLOGY STACK   55

5.4.1.1    5G networks          55

5.4.1.2    Internet of Things                 55

5.4.1.3    Cloud and edge computing 56

5.4.1.4    Blockchain             56

5.4.1.5    Augmented reality, virtual reality, and mixed reality      57

5.4.1.6    Artificial intelligence and machine learning     57

5.5           PORTER’S FIVE FORCES ANALYSIS           57

5.5.1        INTENSITY OF COMPETITIVE RIVALRY 59

5.5.2        BARGAINING POWER OF SUPPLIERS       59

5.5.3        BARGAINING POWER OF BUYERS             59

5.5.4        THREAT OF NEW ENTRANTS      59

5.5.5        THREAT OF SUBSTITUTES          60

5.6           REGULATORY LANDSCAPE         60

5.6.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             60

5.7           VALUE CHAIN ANALYSIS               66

5.7.1        PLANNING & REVISING FUNDS 67

5.7.2        RESEARCH & DEVELOPMENT    67

5.7.3        SOFTWARE DESIGN, FRAMEWORK, AND DEVELOPMENT                67

5.7.4        PRODUCT/SOLUTION PROVIDERS          67

5.7.5        END USERS AND AFTER-SALES SERVICE PROVIDERS                 67

5.8           ECOSYSTEM ANALYSIS  68

5.9           PATENT ANALYSIS          69

5.9.1        INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            69

5.10         ADJACENT MARKET ANALYSIS  72

5.11         CASE STUDY ANALYSIS 73

5.11.1      UTILIZATION OF DIGITAL TWIN TECHNOLOGY FOR

SURGE PLANNING DECISIONS  73

5.11.2      PROVISION OF HOSPITAL GUIDANCE USING DIGITAL TWINS IN

HEALTHCARE DURING COVID-19 PANDEMIC    73

5.11.3      OPTIMIZATION OF CARDIOVASCULAR SOLUTIONS FOR

PERSONALIZED TREATMENTS  74

5.12         KEY STAKEHOLDERS & BUYING CRITERIA            74

5.12.1      KEY STAKEHOLDERS IN BUYING PROCESS           74

5.12.2      BUYING CRITERIA           75

5.13         KEY CONFERENCES & EVENTS, 2025−2026            76

5.14         TRENDS/DISRUPTIONS IMPACTING BUYERS      76

6               DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT    77

6.1           INTRODUCTION              78

6.2           SERVICES             78

6.2.1        INTRODUCTION OF COMPLEX SOFTWARE TO BOOST DEMAND             78

6.3           SOFTWARE         80

6.3.1        TRANSITION TO WEB/CLOUD-BASED MODELS TO PROPEL MARKET             80

7               DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE                 82

7.1           INTRODUCTION              83

7.2           PROCESS TWINS               83

7.2.1        RISING DEMAND FOR HEALTHCARE WORKFLOWS AND OPERATIONAL PROCESSES TO DRIVE MARKET 83

7.3           SYSTEM TWINS 84

7.3.1        INCREASING DEMAND FOR OPERATIONAL EFFICIENCY IN HOSPITALS TO FUEL MARKET              84

7.4           WHOLE BODY TWINS    86

7.4.1        TECHNOLOGICAL ADVANCEMENTS SUCH AS AI AND ML TO FUEL MARKET    86

7.5           BODY PART TWINS         87

7.5.1        GRADUAL PREFERENCE FOR PERSONALIZED & PRECISION

MEDICINE TO SUPPORT MARKET GROWTH        87

8               DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION   89

8.1           INTRODUCTION              90

8.2           DRUG DISCOVERY & DEVELOPMENT     90

8.2.1        ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY &

DEVELOPMENT TO BOOST MARKET      90

8.3           PERSONALIZED MEDICINE          92

8.3.1        COST-EFFECTIVE DEVELOPMENT & TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET GROWTH                 92

8.4           SURGICAL PLANNING & MEDICAL EDUCATION 93

8.4.1        ABILITY ENHANCE TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST DEMAND  93

8.5           MEDICAL DEVICE DESIGN & TESTING   94

8.5.1        MINIMIZING RISKS AND REDUCING DOWNTIME TO DRIVE MARKET 94

8.6           HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT 95

8.6.1        ADVANTAGES SUCH AS IMPROVED EFFICIENCY AND

VALUABLE INSIGHTS TO SUPPORT DEMAND    95

8.7           OTHER APPLICATIONS 97

9               DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER     99

9.1           INTRODUCTION              100

9.2           PHARMA & BIOPHARMA COMPANIES     100

9.2.1        RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND

COST OF DRUG DEVELOPMENT TO BOOST ADOPTION                 100

9.3           RESEARCH & ACADEMIA               102

9.3.1        INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED

BY DIGITAL TWINS TO BOOST ADOPTION          102

9.4           HEALTHCARE PROVIDERS           103

9.4.1        LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH           103

9.5           MEDICAL DEVICE COMPANIES 105

9.5.1        GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION

OF MEDICAL DEVICES TO FUEL GROWTH            105

9.6           OTHER END USERS         106

10            DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION                 108

10.1         INTRODUCTION              109

10.2         NORTH AMERICA             109

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 110

10.2.2      US           113

10.2.2.1  Expanding applications of digital twins in healthcare to

bolster market growth          113

10.2.3      CANADA               115

10.2.3.1  Growing investments in digital twin development to drive market                 115

10.3         EUROPE               117

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      118

10.3.2      GERMANY           120

10.3.2.1  Collaborations & partnerships to drive adoption of digital twins                 120

10.3.3      UK          123

10.3.3.1  Growing applications of digital twins to support growth                 123

10.3.4      FRANCE                125

10.3.4.1  Growing government funding for digital twin development to

bolster growth       125

10.3.5      ITALY    127

10.3.5.1  Rising focus on digital transformation for value-centric patient care to drive market              127

10.3.6      SPAIN    129

10.3.6.1  Rising funding investments for digital health plans to boost market    129

10.3.7      REST OF EUROPE             131

10.4         ASIA PACIFIC     134

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 135

10.4.2      JAPAN   138

10.4.2.1  Growing penetration of digital twin technologies to

support market growth        138

10.4.3      CHINA  140

10.4.3.1  China to register highest CAGR during forecast period 140

10.4.4      INDIA    142

10.4.4.1  Improvements in healthcare infrastructure to support market growth    142

10.4.5      REST OF ASIA PACIFIC   144

10.5         LATIN AMERICA                146

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 146

10.5.2      BRAZIL 149

10.5.2.1  Favorable digitization investments to support market growth                 149

10.5.3      MEXICO                151

10.5.3.1  Supportive government strategies to fuel uptake            151

10.5.4      REST OF LATIN AMERICA             153

10.6         MIDDLE EAST & AFRICA                155

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 155

10.6.2      GCC COUNTRIES              157

10.6.2.1  Increasing healthcare infrastructure development and investments to support market growth              157

10.6.3      REST OF MIDDLE EAST AND AFRICA       159

11            COMPETITIVE LANDSCAPE         162

11.1         OVERVIEW          162

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            162

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET    162

11.3         REVENUE ANALYSIS, 2020−2024                 164

11.4         MARKET SHARE ANALYSIS, 2024                 165

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 167

11.5.1      STARS   167

11.5.2      EMERGING LEADERS     167

11.5.3      PERVASIVE PLAYERS      168

11.5.4      PARTICIPANTS 168

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         169

11.5.5.1  Region footprint   169

11.5.5.2  Company footprint               170

11.5.5.3  Component footprint           171

11.5.5.4  Application footprint            172

11.5.5.5  End-user footprint                173

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        174

11.6.1      PROGRESSIVE COMPANIES         174

11.6.2      RESPONSIVE COMPANIES            174

11.6.3      DYNAMIC COMPANIES  174

11.6.4      STARTING BLOCKS         174

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 176

11.6.5.1  Detailed list of key startups/SME players         176

11.6.5.2  Competitive benchmarking of key startups/SME players                 177

11.7         COMPANY VALUATION & FINANCIAL METRICS 178

11.7.1      FINANCIAL METRICS      178

11.7.2      COMPANY VALUATION 178

11.8         BRAND/SOFTWARE COMPARISON           179

11.9         COMPETITIVE SCENARIO             180

11.9.1      PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS        180

11.9.2      DEALS  181

11.9.3      EXPANSIONS     184

11.9.4      OTHER DEVELOPMENTS              184

12            COMPANY PROFILES      185

12.1         KEY PLAYERS     185

12.1.1      MICROSOFT CORPORATION      185

12.1.1.1  Business overview 185

12.1.1.2  Products/Services offered   186

12.1.1.3  Recent developments           187

12.1.1.3.1                Deals      187

12.1.1.4  MnM view              187

12.1.1.4.1                Key strengths        187

12.1.1.4.2                Strategic choices   187

12.1.1.4.3                Weaknesses & competitive threats     188

12.1.2      SIEMENS HEALTHINEERS AG      189

12.1.2.1  Business overview 189

12.1.2.2  Products/Services offered   190

12.1.2.3  Recent developments           191

12.1.2.3.1                Deals      191

12.1.2.4  MnM view              191

12.1.2.4.1                Key strengths        191

12.1.2.4.2                Strategic choices   192

12.1.2.4.3                Weaknesses & competitive threats     192

12.1.3      KONINKLIJKE PHILIPS N.V.          193

12.1.3.1  Business overview 193

12.1.3.2  Products/Services offered   194

12.1.3.3  Recent developments           195

12.1.3.3.1                Deals      195

12.1.3.4  MnM view              195

12.1.3.4.1                Key strengths        195

12.1.3.4.2                Strategic choices   195

12.1.3.4.3                Weaknesses & competitive threats     195

12.1.4      AMAZON WEB SERVICES, INC.    196

12.1.4.1  Business overview 196

12.1.4.2  Products/Services offered   197

12.1.4.3  Recent developments           198

12.1.4.3.1                Product/Service launches & enhancements     198

12.1.4.3.2                Deals      198

12.1.4.4  MnM view              198

12.1.4.4.1                Key strengths        198

12.1.4.4.2                Strategic choices   199

12.1.4.4.3                Weaknesses & competitive threats     199

12.1.5      DASSAULT SYSTÈMES   200

12.1.5.1  Business overview 200

12.1.5.2  Products/Services offered   201

12.1.5.3  Recent developments           202

12.1.5.3.1                Product/Service launches & enhancements     202

12.1.5.3.2                Deals      203

12.1.5.4  MnM view              204

12.1.5.4.1                Key strengths        204

12.1.5.4.2                Strategic choices   204

12.1.5.4.3                Weaknesses & competitive threats     204

12.1.6      GE HEALTHCARE             205

12.1.6.1  Business overview 205

12.1.6.2  Products/Services offered   206

12.1.6.3  Recent developments           207

12.1.6.3.1                Deals      207

12.1.7      ORACLE CORPORATION               208

12.1.7.1  Business overview 208

12.1.7.2  Products/Services offered   209

12.1.7.3  Recent developments           210

12.1.7.3.1                Product/Service enhancements          210

12.1.7.3.2                Deals      210

12.1.7.3.3                Expansions             211

12.1.8      IBM        212

12.1.8.1  Business overview 212

12.1.8.2  Products/Services offered   213

12.1.8.3  Recent developments           214

12.1.8.3.1                Deals      214

12.1.9      PTC        215

12.1.9.1  Business overview 215

12.1.9.2  Products/Services offered   216

12.1.9.3  Recent developments           217

12.1.9.3.1                Product/Service launches   217

12.1.9.3.2                Deals      217

12.1.10   SAP         218

12.1.10.1                 Business overview 218

12.1.10.2                 Products/Services offered   219

12.1.10.3                 Recent developments           220

12.1.10.3.1             Deals      220

12.1.10.3.2             Other developments             220

12.1.11   ATOS SE               221

12.1.11.1                 Business overview 221

12.1.11.2                 Products/Services offered   222

12.1.11.3                 Recent developments           222

12.1.11.3.1             Deals      222

12.1.12   NVIDIA CORPORATION 223

12.1.12.1                 Business overview 223

12.1.12.2                 Products/Services offered   224

12.1.12.3                 Recent developments           225

12.1.12.3.1             Product/Service launches   225

12.1.12.3.2             Deals      226

12.1.13   ANSYS INC.          227

12.1.13.1                 Business overview 227

12.1.13.2                 Products/Services offered   228

12.1.13.3                 Recent developments           229

12.1.13.3.1             Product/Service launches   229

12.1.13.3.2             Deals      229

12.1.14   FASTSTREAM TECHNOLOGIES  231

12.1.14.1                 Business overview 231

12.1.14.2                 Products/Services offered   231

12.1.15   RESCALE, INC.   232

12.1.15.1                 Business overview 232

12.1.15.2                 Products/Services offered   232

12.2         OTHER PAYERS 233

12.2.1      TWIN HEALTH  233

12.2.1.1  Business overview 233

12.2.1.2  Products/Services offered   233

12.2.1.3  Recent developments           233

12.2.1.3.1                Other developments             233

12.2.2      VERTO  234

12.2.2.1  Business overview 234

12.2.2.2  Products/Services offered   234

12.2.2.3  Recent developments           235

12.2.2.3.1                Deals      235

12.2.3      QBIO     236

12.2.3.1  Business overview 236

12.2.3.2  Products/Services offered   236

12.2.3.3  Recent developments           236

12.2.3.3.1                Product/Service launches   236

12.2.4      THOUGHTWIRE                237

12.2.4.1  Business overview 237

12.2.4.2  Products/Services offered   237

12.2.5      SIM AND CURE  238

12.2.5.1  Business overview 238

12.2.5.2  Products/Services offered   238

12.2.6      PREDICTIV         239

12.2.6.1  Business overview 239

12.2.6.2  Products/Services offered   239

12.2.7      NUREA 240

12.2.7.1  Business overview 240

12.2.7.2  Products/Services offered   240

12.2.7.3  Recent developments           240

12.2.7.3.1                Product/Service approvals  240

12.2.7.3.2                Deals      241

12.2.8      UNLEARN.AI, INC.            242

12.2.8.1  Business overview 242

12.2.8.2  Products/Services offered   242

12.2.8.3  Recent developments           243

12.2.8.3.1                Deals      243

12.2.8.3.2                Other developments             243

12.2.9      VIRTONOMY GMBH        244

12.2.9.1  Business overview 244

12.2.9.2  Products/Services offered   244

12.2.10   PREDISURGE     245

12.2.10.1                 Business overview 245

12.2.10.2                 Products/Services offered   245

12.2.10.3                 Recent developments           246

12.2.10.3.1             Deals      246

12.2.10.3.2             Other developments             246

13            APPENDIX           247

13.1         DISCUSSION GUIDE        247

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                251

13.3         CUSTOMIZATION OPTIONS        253

13.4         RELATED REPORTS         253

13.5         AUTHOR DETAILS           254

LIST OF TABLES

TABLE 1                DIGITAL TWINS IN HEALTHCARE MARKET: INCLUSIONS & EXCLUSIONS       27

TABLE 2                DIGITAL TWINS IN HEALTHCARE MARKET: STUDY ASSUMPTIONS  38

TABLE 3                DIGITAL TWINS IN HEALTHCARE MARKET: RISK ASSESSMENT ANALYSIS 38

TABLE 4                MARKET DYNAMICS: DIGITAL TWINS IN HEALTHCARE MARKET 49

TABLE 5                DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS           58

TABLE 6                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  60

TABLE 7                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  61

TABLE 8                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  62

TABLE 9                REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  63

TABLE 10              DIGITAL TWINS IN HEALTHCARE MARKET: REGULATORY STANDARDS         64

TABLE 11              KEY PATENTS IN DIGITAL TWINS IN HEALTHCARE MARKET 71

TABLE 12              CASE STUDY 1: UTILIZATION OF DIGITAL TWIN TECHNOLOGY

FOR SURGE PLANNING DECISIONS         73

TABLE 13              CASE STUDY 2: PROVISION OF HOSPITAL GUIDANCE USING

DIGITAL TWINS IN HEALTHCARE DURING COVID-19 PANDEMIC                 73

TABLE 14              CASE STUDY 3: OPTIMIZATION OF CARDIOVASCULAR SOLUTIONS FOR PERSONALIZED TREATMENTS   74

TABLE 15              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)     75

TABLE 16              KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS  75

TABLE 17              DIGITAL TWINS IN HEALTHCARE MARKET: KEY CONFERENCES & EVENTS, 2025−2026     76

TABLE 18              DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            78

TABLE 19              DIGITAL TWINS IN HEALTHCARE SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            79

TABLE 20              KEY SOFTWARE SOLUTIONS OFFERED BY MARKET PLAYERS           80

TABLE 21              DIGITAL TWINS IN HEALTHCARE SOFTWARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            81

TABLE 22              DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2023–2030 (USD MILLION)                83

TABLE 23              PROCESS TWINS CURRENTLY OFFERED BY MARKET PLAYERS           84

TABLE 24              PROCESS TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       84

TABLE 25              SYSTEM TWINS CURRENTLY OFFERED BY MARKET PLAYERS           85

TABLE 26              SYSTEM TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       85

TABLE 27              WHOLE BODY TWINS CURRENTLY OFFERED BY MARKET PLAYERS           86

TABLE 28              WHOLE BODY TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            87

TABLE 29              BODY PART TWINS CURRENTLY OFFERED BY MARKET PLAYERS           88

TABLE 30              BODY PART TWINS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            88

TABLE 31              DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            90

TABLE 32              DIGITAL TWINS IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 91

TABLE 33              DIGITAL TWINS IN HEALTHCARE MARKET FOR PERSONALIZED MEDICINE,

BY COUNTRY, 2023–2030 (USD MILLION)               93

TABLE 34              DIGITAL TWINS IN HEALTHCARE MARKET FOR SURGICAL PLANNING &

MEDICAL EDUCATION, BY COUNTRY, 2023–2030 (USD MILLION)                 94

TABLE 35              DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE

DESIGN & TESTING, BY COUNTRY, 2023–2030 (USD MILLION)                 95

TABLE 36              DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION)                 96

TABLE 37              DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               98

TABLE 38              DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            100

TABLE 39              DIGITAL TWINS IN HEALTHCARE MARKET FOR PHARMA &

BIOPHARMA COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)            101

TABLE 40              DIGITAL TWINS IN HEALTHCARE MARKET FOR RESEARCH & ACADEMIA,

BY COUNTRY, 2023–2030 (USD MILLION)               103

TABLE 41              DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,

BY COUNTRY, 2023–2030 (USD MILLION)               104

TABLE 42              DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE COMPANIES,

BY COUNTRY, 2023–2030 (USD MILLION)               106

TABLE 43              DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)                 107

TABLE 44              DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION, 2023–2030 (USD MILLION)          109

TABLE 45              NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            111

TABLE 46              NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION)            111

TABLE 47              NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            111

TABLE 48              NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            112

TABLE 49              NORTH AMERICA: DIGITAL TWINS IN MARKET, BY END USER,

2023–2030 (USD MILLION)            112

TABLE 50              US: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            113

TABLE 51              US: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            114

TABLE 52              US: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            114

TABLE 53              US: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            115

TABLE 54              CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            115

TABLE 55              CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            116

TABLE 56              CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            116

TABLE 57              CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            117

TABLE 58              EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            118

TABLE 59              EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            118

TABLE 60              EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            119

TABLE 61              EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            119

TABLE 62              EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            120

TABLE 63              GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            121

TABLE 64              GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            121

TABLE 65              GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            122

TABLE 66              GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            122

TABLE 67              UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            123

TABLE 68              UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            124

TABLE 69              UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            124

TABLE 70              UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            125

TABLE 71              FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            126

TABLE 72              FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            126

TABLE 73              FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            126

TABLE 74              FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            127

TABLE 75              ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            127

TABLE 76              ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            128

TABLE 77              ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            128

TABLE 78              ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            129

TABLE 79              SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            129

TABLE 80              SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            130

TABLE 81              SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            130

TABLE 82              SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            131

TABLE 83              REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION)            132

TABLE 84              REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            132

TABLE 85              REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            133

TABLE 86              REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            133

TABLE 87              ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            136

TABLE 88              ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            136

TABLE 89              ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            136

TABLE 90              ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            137

TABLE 91              ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            137

TABLE 92              JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            138

TABLE 93              JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            138

TABLE 94              JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            139

TABLE 95              JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            139

TABLE 96              CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            140

TABLE 97              CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            140

TABLE 98              CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            141

TABLE 99              CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            141

TABLE 100            INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            142

TABLE 101            INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            143

TABLE 102            INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            143

TABLE 103            INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            144

TABLE 104            REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION)            144

TABLE 105            REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            145

TABLE 106            REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            145

TABLE 107            REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)            146

TABLE 108            LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            147

TABLE 109            LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION)            147

TABLE 110            LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            147

TABLE 111            LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            148

TABLE 112            LATIN AMERICA: DIGITAL TWINS IN MARKET, BY END USER,

2023–2030 (USD MILLION)            148

TABLE 113            BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            149

TABLE 114            BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            149

TABLE 115            BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            150

TABLE 116            BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            150

TABLE 117            MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2023–2030 (USD MILLION)            151

TABLE 118            MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            151

TABLE 119            MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            152

TABLE 120            MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            152

TABLE 121            REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY COMPONENT, 2023–2030 (USD MILLION)        153

TABLE 122            REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)         153

TABLE 123            REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       154

TABLE 124            REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY END USER, 2023–2030 (USD MILLION)               154

TABLE 125            MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 126            MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY COMPONENT, 2023–2030 (USD MILLION)        156

TABLE 127            MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)         156

TABLE 128            MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       156

TABLE 129            MIDDLE EAST & AFRICA: DIGITAL TWINS IN MARKET, BY END USER,

2023–2030 (USD MILLION)            157

TABLE 130            GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION)            158

TABLE 131            GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            158

TABLE 132            GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            158

TABLE 133            GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2023–2030 (USD MILLION)            159

TABLE 134            REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 159

TABLE 135            REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2023–2030 (USD MILLION)            160

TABLE 136            REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160

TABLE 137            REST OF THE MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2023–2030 (USD MILLION)            161

TABLE 138            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN

DIGITAL TWINS IN HEALTHCARE MARKET, JANUARY 2021–MARCH 2025       162

TABLE 139            DIGITAL TWINS IN HEALTHCARE MARKET: DEGREE OF COMPETITION         165

TABLE 140            DIGITAL TWINS IN HEALTHCARE MARKET: REGION FOOTPRINT     169

TABLE 141            DIGITAL TWINS IN HEALTHCARE MARKET: COMPONENT FOOTPRINT          171

TABLE 142            DIGITAL TWINS IN HEALTHCARE MARKET: APPLICATION FOOTPRINT         172

TABLE 143            DIGITAL TWINS IN HEALTHCARE MARKET: END-USER FOOTPRINT 173

TABLE 144            DIGITAL TWINS IN HEALTHCARE MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2021–MARCH 2025              180

TABLE 145            DIGITAL TWINS IN HEALTHCARE MARKET: DEALS, JANUARY 2021–JANUARY 2025      181

TABLE 146            DIGITAL TWINS IN HEALTHCARE MARKET:

EXPANSIONS, JANUARY 2021–MARCH 2025            184

TABLE 147            DIGITAL TWINS IN HEALTHCARE MARKET:

OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025    184

TABLE 148            MICROSOFT CORPORATION: COMPANY OVERVIEW          185

TABLE 149            MICROSOFT CORPORATION: PRODUCTS/SERVICES OFFERED               186

TABLE 150            MICROSOFT CORPORATION: DEALS, JANUARY 2021–MARCH 2025             187

TABLE 151            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          189

TABLE 152            SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED               190

TABLE 153            SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–MARCH 2025             191

TABLE 154            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          193

TABLE 155            KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED               194

TABLE 156            KONINKLIJKE PHILIPS N.V: DEALS, JANUARY 2021–MARCH 2025             195

TABLE 157            AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW          196

TABLE 158            AMAZON WEB SERVICES, INC.: PRODUCTS/SERVICES OFFERED               197

TABLE 159            AMAZON WEB SERVICES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021–MARCH 2025             198

TABLE 160            AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2021–MARCH 2025             198

TABLE 161            DASSAULT SYSTÈMES: COMPANY OVERVIEW                 200

TABLE 162            DASSAULT SYSTÈMES: PRODUCTS/SERVICES OFFERED             201

TABLE 163            DASSAULT SYSTÈMES: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021–MARCH 2025                 202

TABLE 164            DASSAULT SYSTÈMES: DEALS, JANUARY 2021–MARCH 2025       203

TABLE 165            GE HEALTHCARE: COMPANY OVERVIEW                 205

TABLE 166            GE HEALTHCARE: PRODUCTS/SERVICES OFFERED             206

TABLE 167            GE HEALTHCARE: DEALS, JANUARY 2021–MARCH 2025       207

TABLE 168            ORACLE CORPORATION: COMPANY OVERVIEW                 208

TABLE 169            ORACLE CORPORATION: PRODUCTS/SERVICES OFFERED             209

TABLE 170            ORACLE CORPORATION: PRODUCT/SERVICE ENHANCEMENTS,

JANUARY 2021–MARCH 2025         210

TABLE 171            ORACLE CORPORATION: DEALS, JANUARY 2021–MARCH 2025       210

TABLE 172            ORACLE CORPORATION: EXPANSIONS, JANUARY 2021–MARCH 2025         211

TABLE 173            IBM: COMPANY OVERVIEW         212

TABLE 174            IBM: PRODUCTS/SERVICES OFFERED    213

TABLE 175            IBM: DEALS, JANUARY 2021–MARCH 2025                 214

TABLE 176            PTC: COMPANY OVERVIEW         215

TABLE 177            PTC: PRODUCTS/SERVICES OFFERED    216

TABLE 178            PTC: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–MARCH 2025             217

TABLE 179            PTC: DEALS, JANUARY 2021–MARCH 2025                 217

TABLE 180            SAP: COMPANY OVERVIEW         218

TABLE 181            SAP: PRODUCTS/SERVICES OFFERED     219

TABLE 182            SAP: DEALS, JANUARY 2021–MARCH 2025                 220

TABLE 183            SAP: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025       220

TABLE 184            ATOS SE: COMPANY OVERVIEW                221

TABLE 185            ATOS SE: PRODUCTS/SERVICES OFFERED                 222

TABLE 186            ATOS SE: DEALS, JANUARY 2021–MARCH 2025                 222

TABLE 187            NVIDIA CORPORATION: COMPANY OVERVIEW                 223

TABLE 188            NVIDIA CORPORATION: PRODUCTS/SERVICES OFFERED             224

TABLE 189            NVIDIA CORPORATION: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021–MARCH 2025         225

TABLE 190            NVIDIA CORPORATION: DEALS, JANUARY 2021–MARCH 2025       226

TABLE 191            ANSYS INC.: COMPANY OVERVIEW          227

TABLE 192            ANSYS INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–MARCH 2025         229

TABLE 193            ANSYS INC.: DEALS, JANUARY 2021–MARCH 2025                 229

TABLE 194            FASTSTREAM TECHNOLOGIES: COMPANY OVERVIEW          231

TABLE 195            FASTSTREAM TECHNOLOGIES: PRODUCTS/SERVICES OFFERED               231

TABLE 196            RESCALE, INC.: COMPANY OVERVIEW    232

TABLE 197            RESCALE, INC.: PRODUCTS/SERVICES OFFERED                 232

TABLE 198            TWIN HEALTH: COMPANY OVERVIEW   233

TABLE 199            TWIN HEALTH: PRODUCTS/SERVICES OFFERED                 233

TABLE 200            TWIN HEALTH: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025         233

TABLE 201            VERTO: COMPANY OVERVIEW  234

TABLE 202            VERTO PRODUCTS/SERVICES OFFERED                 234

TABLE 203            VERTO: DEALS, JANUARY 2021–MARCH 2025                 235

TABLE 204            QBIO: COMPANY OVERVIEW      236

TABLE 205            QBIO: PRODUCTS/SERVICES OFFERED 236

TABLE 206            QBIO: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–MARCH 2025         236

TABLE 207            THOUGHTWIRE: COMPANY OVERVIEW                 237

TABLE 208            THOUGHTWIRE: PRODUCTS/SERVICES OFFERED             237

TABLE 209            SIM AND CURE: COMPANY OVERVIEW  238

TABLE 210            SIM AND CURE: PRODUCTS/SERVICES OFFERED                 238

TABLE 211            PREDICTIV: COMPANY OVERVIEW          239

TABLE 212            PREDICTIV: PRODUCTS/SERVICES OFFERED                 239

TABLE 213            NUREA: COMPANY OVERVIEW  240

TABLE 214            NUREA: PRODUCTS/SERVICES OFFERED                 240

TABLE 215            NUREA: PRODUCT/SERVICE APPROVALS, JANUARY 2021–MARCH 2025         240

TABLE 216            NUREA: DEALS, JANUARY 2021–MARCH 2025                 241

TABLE 217            UNLEARN.AI, INC.: COMPANY OVERVIEW                 242

TABLE 218            UNLEARN.AI, INC.: PRODUCTS/SERVICES OFFERED             242

TABLE 219            UNLEARN.AI, INC.: DEALS, JANUARY 2021–MARCH 2025       243

TABLE 220            UNLEARN.AI, INC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025         243

TABLE 221            VIRTONOMY GMBH: BUSINESS OVERVIEW                 244

TABLE 222            VIRTONOMY GMBH: PRODUCTS/SERVICES OFFERED             244

TABLE 223            PREDISURGE: COMPANY OVERVIEW      245

TABLE 224            PREDISURGE: PRODUCTS/SERVICES OFFERED                 245

TABLE 225            PREDISURGE: DEALS, JANUARY 2021–MARCH 2025        246

TABLE 226            PREDISURGE: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025         246

LIST OF FIGURES

FIGURE 1              DIGITAL TWINS IN HEALTHCARE MARKET:

SEGMENTATION & GEOGRAPHIC SPREAD           26

FIGURE 2              DIGITAL TWINS IN HEALTHCARE MARKET: YEARS CONSIDERED      28

FIGURE 3              RESEARCH DESIGN         29

FIGURE 4              PRIMARY SOURCES         31

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     32

FIGURE 6              BOTTOM-UP APPROACH              34

FIGURE 7              TOP-DOWN APPROACH                34

FIGURE 8              CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF DIGITAL TWINS IN HEALTHCARE INDUSTRY                 35

FIGURE 9              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 36

FIGURE 10            DIGITAL TWINS IN HEALTHCARE MARKET: DATA TRIANGULATION                37

FIGURE 11            DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,

2025 VS. 2030 (USD MILLION)      40

FIGURE 12            DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)         41

FIGURE 13            DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      42

FIGURE 14            DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      43

FIGURE 15            GEOGRAPHIC SNAPSHOT OF DIGITAL TWINS IN HEALTHCARE MARKET 44

FIGURE 16            INCREASING USE OF DIGITAL TWINS AND GROWING IMPORTANCE OF

PATIENT-CENTRIC HEALTHCARE TO PROPEL MARKET                 45

FIGURE 17            SOFTWARE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US IN 2025                 46

FIGURE 18            CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD         46

FIGURE 19            ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD           47

FIGURE 20            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    47

FIGURE 21            DIGITAL TWINS IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     48

FIGURE 22            DIGITAL TWIN TECHNOLOGIES                55

FIGURE 23            DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS           58

FIGURE 24            VALUE CHAIN ANALYSIS               66

FIGURE 25            DIGITAL TWINS IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS  68

FIGURE 26            GLOBAL PATENT PUBLICATION TRENDS IN DIGITAL TWINS IN HEALTHCARE MARKET, 2017–2024     69

FIGURE 27            TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR DIGITAL TWIN PATENTS (JANUARY 2017–DECEMBER 2024)              70

FIGURE 28            TOP APPLICANTS FOR DIGITAL TWIN PATENTS (COUNTRY/REGION) (JANUARY 2017–DECEMBER 2024) 70

FIGURE 29            METAVERSE IN HEALTHCARE MARKET: MARKET OVERVIEW       72

FIGURE 30            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS              74

FIGURE 31            KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS  75

FIGURE 32            DIGITAL TWINS IN HEALTHCARE MARKET: TRENDS/DISRUPTIONS

IMPACTING BUYERS      76

FIGURE 33            NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT         110

FIGURE 34            ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT       135

FIGURE 35            REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL TWINS IN

HEALTHCARE MARKET, 2020–2024 (USD MILLION)           164

FIGURE 36            MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL TWINS IN

HEALTHCARE MARKET (2024)    165

FIGURE 37            DIGITAL TWINS IN HEALTHCARE MARKET:

COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024  168

FIGURE 38            DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY FOOTPRINT 170

FIGURE 39            DIGITAL TWINS IN HEALTHCARE MARKET:

COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 175

FIGURE 40            EV/EBITDA OF KEY VENDORS   178

FIGURE 41            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND

5-YEAR STOCK BETA OF KEY VENDORS 178

FIGURE 42            DIGITAL TWINS IN HEALTHCARE MARKET: BRAND/SOFTWARE COMPARISON           179

FIGURE 43            MICROSOFT CORPORATION: COMPANY SNAPSHOT (2024)             186

FIGURE 44            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)             190

FIGURE 45            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)             194

FIGURE 46            AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2024)             197

FIGURE 47            DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2024)    201

FIGURE 48            GE HEALTHCARE: COMPANY SNAPSHOT (2024)                 206

FIGURE 49            ORACLE CORPORATION: COMPANY SNAPSHOT (2024)    209

FIGURE 50            IBM: COMPANY SNAPSHOT (2024)            213

FIGURE 51            PTC: COMPANY SNAPSHOT (2024)            216

FIGURE 52            SAP: COMPANY SNAPSHOT (2024)             219

FIGURE 53            ATOS SE: COMPANY SNAPSHOT (2024)   221

FIGURE 54            NVIDIA CORPORATION: COMPANY SNAPSHOT (2024)    224

FIGURE 55            ANSYS INC.: COMPANY SNAPSHOT (2023)                 228